Program Overview
Release Date: March 1, 2008 Expiration Date: February 28, 2009
Continuing Education Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program provides 2.5 hours (0.25 CEUs) of continuing education credit (program number 204-000-07-473-H01P).
Methods/Format
This is an online activity consisting of audio, presentation slides, post-test, and activity evaluation tool. Participants must view the entire presentation, take the activity post-test, and complete the course evaluation to receive continuing education credit. Click on the “Take Post Test” tab to proceed to the ASHP Advantage CE Testing Center and take the post-test online. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time required to complete this activity is 2.5 hours. This activity is provided free of charge.
Target Audience
This activity was planned to meet the needs of pharmacists who have an interest in, treat, instruct, or otherwise participate in the care of patients with chronic obstructive pulmonary disease or need an update on the disease state.
Activity Content
Click here to view an overview of the activity content.
Learning Objectives
After participating in this educational activity, participants should be able to
- Describe the clinical course of COPD and its long-term consequences for patients, the families, and society.
- Identify the etiology, symptoms, and signs of severity of COPD.
- Describe the role and benefits of β2 agonists, anticholinergics, and corticosteroids in the long-term management of COPD.
- Develop therapeutic plans for managing COPD, including strategies for smoking cessation, education on the appropriate use of devices, and considerations in self-management.
Faculty
Dennis M. Williams, Pharm.D., BCPS, AE-C (Program Chair)
Associate Professor
Division of Pharmacotherapy and Experimental Therapeutics
School of Pharmacy
University of North Carolina
Chapel Hill, North Carolina
James F. Donohue, M.D.
Professor of Medicine and Division Chief
Pulmonary Diseases & Critical Care Medicine
School of Medicine
University of North Carolina
Chapel Hill, North Carolina
Disclosure Statements
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.
The faculty and planners report the following relationships:
Dennis M. Williams, Pharm.D., BCPS, AE-C
Dr. Williams declares that he serves on the speakers bureaus for Sepracor, Boehringer Ingelheim, and Astra Zeneca and that his spouse is employed by GlaxoSmithKline.
James F. Donohue, M.D.
Dr. Donohue declares that he has received research grants and has served as a consultant to GlaxoSmithKline, Novartis, Boehringer Ingelheim, Pfizer, Sepracor, and Astra Zeneca.
Sandra Oh Clarke, R.Ph.
Ms Oh Clarke declares that she has no relationships pertinent to this activity.
This activity is supported by an educational grant from Sepracor.
Launch Presentation
Presented by Dennis M. Williams, Pharm.D., BCPS, AE-C
Presented by James F. Donohue, M.D.
Presented by Dennis M. Williams, Pharm.D., BCPS, AE-C
Presented by Dennis M. Williams, Pharm.D., BCPS, AE-C
If you would prefer a podcast format of this activity, click here.
Download Post-Test
Click Here to print the post-test for your reference. Please note that to be eligible for continuing education credit, you must go to the ASHP Advantage Testing Center and complete the test online.
